As you might’ve heard, CVS and Walgreens have pulled Zantac® and ranitidine from their shelves in response to new information from the FDA. We stopped selling ranitidine as soon as the FDA issued its warning in mid-September, and we won’t reissue it until we’re certain it’s safe.
Here’s what you need to know:
- The cause for concern is a possible carcinogen (a chemical that may cause cancer) called nitrosodimethylamine (NDMA), which was found in low levels in the ranitidine the FDA tested.
- The FDA hasn’t recalled ranitidine or Zantac® just yet. That’s because there’s no solid evidence that the levels of NDMA in ranitidine pose a risk to people who take it. (The studies that determined that NDMA might cause cancer were done on animals, not people.)
- NDMA isn’t an immediate risk to your health. It’s also found in the environment and some meat, vegetables, and dairy products.
- You can get the most up-to-date information from the FDA here.
While we wait for more information, we want to remind you that you have other options. If you’re currently taking ranitidine, you may want to switch to antacids for immediate symptom relief. You could also consider trying a proton pump inhibitor (PPI) like esomeprazole or omeprazole for long-term relief, especially if your symptoms are moderate or severe. You can take PPIs along with antacids if you need to.
We want to make sure you have all the information you need to make the best decisions for your health. If you have any questions at all, feel free to reach out to email@example.com anytime.